Journal of Parkinson's Disease and Movement Disorders

The molecular and genetic view of tauopathies: From structural polymorphism to systemic neurodegeneration

Esra Demir Ünal, Selim Selçuk Çomoğlu

DOI: 10.5606/phhb.dergisi.2026.66

Issue: 2026, Volume 29 - Issue 2
168 211

Sleep disturbances and their clinical correlates in patients with hemifacial spasm

Özge Gönül Öner, Gözde Baran

DOI: 10.5606/phhb.dergisi.2026.79

Issue: 2026, Volume 29 - Issue 2
154 181

Candidate profile and clinical characteristics of patients undergoing STN-DBS surgery for advanced Parkinson's disease: A single-center experience

Gülce Coşku Yılmaz Çakan, Gökhan Gürkan, Ali Akay, Özge Yılmaz Küsbeci

DOI: 10.5606/phhb.dergisi.2026.71

Issue: 2026, Volume 29 - Issue 2
158 151

Comparison of botulinum toxin type A administered at different dilutions in patients with clonic hemifacial spasm

Hanife Şentürk, İlknur Güçlü Altun, Banu Özen Barut

DOI: 10.5606/phhb.dergisi.2026.77

Issue: 2026, Volume 29 - Issue 2
136 144

Comparative evaluation of neuropsychiatric and psychometric parameters in patients with functional movement disorder

Miray Erdem, Elif Banu Söker, Şencan Buturak, Mehmet Balal

DOI: 10.5606/phhb.dergisi.2026.81

Issue: 2026, Volume 29 - Issue 2
114 131

Sydenham's chorea exacerbated in late adulthood: A rare case report

Meral Öksüz, Zehra Yavuz, Özlem Bizpınar Munis, Selim Selçuk Çomoğlu

DOI: 10.5606/phhb.dergisi.2026.37

Issue: 2026, Volume 29 - Issue 2
112 125

Acetazolamide-associated lingual myokymia: A reversible peripheral nerve hyperexcitability phenotype

Esra Demir Ünal, Nur Dilara Çağman

DOI: 10.5606/phhb.dergisi.2026.62

Issue: 2026, Volume 29 - Issue 2
158 149